XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Income (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Net sales $ 3,649 $ 3,707
Cost of sales 2,302 2,359
Gross margin 1,347 1,348
Selling, general and administrative expenses 1,010 1,052
Research and development expenses 164 150
Other operating income, net (13) (17)
Operating income 186 163
Interest expense, net 117 85
Other income, net (1) (16)
Income before income taxes 70 94
Income tax expense 25 21
Net income 45 73
Net income attributable to noncontrolling interests 1 2
Net income attributable to Baxter stockholders $ 44 $ 71
Earnings per share    
Basic (in dollars per share) $ 0.09 $ 0.14
Diluted (in dollars per share) $ 0.09 $ 0.14
Weighted-average number of shares outstanding    
Basic (in shares) 505 503
Diluted (in shares) 507 509